am sitting on this one and topping up. Under a scenario whereby TLX250-CDx and TLX-591 (approval expected late 2026) are fully approved and de-risked, Jarden builds to a $13. 97 Sentiment: None Disclosure: HeldI've said this before, but I think the next great financial milestone I've set for TLX is that they start banking double digit profits per quarter. ASX - General. THE CALMER CO INTERNATIONAL LIMITED. If volume can increase in. Created with Sketch. In this context, the broker expects ASX-listed Telix Pharmaceuticals’ (ASX:TLX) radiopharmaceutical imaging product, Illucix, to increase revenues to the Oz healthcare stock for years to come. Telix is a biotech firm that is developing molecularly targeted. Commodities. , page-6. Well, it’s really hard to predict with certainty. TLX plans to align SENSEI with its Illuccix programs for prostate cancer. 46. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for Pluvicto ® (lutetium [ 177 Lu] vipivotide tetraxetan), for the treatment of. Not so much great volume, but this second attempt MIGHT stick. Telix Pharmaceuticals (TLX) 2022 sees Telix become a commercial entity withfirst approved product in ILLUCCIX. 10A Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) advises that ordinary shares voluntarily escrowed by China Grand Pharmaceutical and Healthcare Holdings Limited following the strategic commercial partnership and placement announced 2 November 2020, are to be released from. its non-material $. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. 12. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. TLX expects Tx will be the fastest growing portion of. That level of long-term growth would reflect the rapid progress being made by the business through the early development of its products – i. That linear projection gives me AUS$100m for Q1 2023. MELBOURNE, Australia and LIEGE, Belgium, Sept. Created with Sketch. Feb 7 (Reuters) - Telix Pharmaceuticals Ltd (TLX) : TELIX PHARMACEUTICALS LTD - JAPANESE PROSTATE CANCER IMAGING TRIAL. Pharma giant Pfizer [PFE] is to buy cancer-focused biotech Seagen [SGEN] for $43bn or $229 per share, a 16% premium on its Monday closing price of $197. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. 7 in 12 weeks that could be the sleeper as it would add a further $15m ++ to. No, but if CB said TLX was treating 2000 men a week back in 12th May, I think that's around $70 million for the 7 weeks to June 30th. $8 coming, page-4. ASX - By Stock. Share something technical analysis wont tell you is when an external event will affect a share price. 63. 5017. TLX591 177Lu-rosopatamab may have an advantage as I understand it is 2 administrations with a short duration apart. No, but if CB said TLX was treating 2000 men a week back in 12th May, I think that's around $70 million for the 7 weeks to June 30th. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. Telix is a global, commercial-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using targeted radiation. Add to watchlist. HotCopper has news, discussion, prices and market data on EV RESOURCES LTD. Timeline. govIdentifier. . 50pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on TALGA GROUP LTD. IPOs. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. TLX is the ASX code for Telix Pharmaceuticals Limited, a radiopharmaceutical company based in Australia. If they were interested (they're probably not). Created with Sketch. Tlx prostate therapy overall survival 48 months as opposed Novartis 10 months . 50, gaps remain in chart @ ~$11. Join the HotCopper ASX share market forum today for free. (QSAM) and its lead asset, CycloSam® (Samarium-153-DOTMP). TLX Price at posting: $6. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. Share something technical analysis wont tell you is when an external event will affect a share price. Join the HotCopper ASX. and going into end of fin year - funds will want TLX on their books. an. Share something technical analysis wont tell you is when an external event will affect a share price. 40 a share. 59pm 20/11/2023 ? Share Prices & Charts for TELIX PHARMACEUTICALS LIMITED. Created with Sketch. MarketIt should show trade and receivables as of 30th June 2023. The Board announces that it has initiated a partial divestment of the Group’s shareholding in Telix Pharmaceuticals Limited (“Telix”, a company listed in the Australian Securities Exchange, stock code: TLX) to sell, off the market, approximately half of its holding (10,000,000 shares) in Telix at a value of approximately AU$73 million. 4 Upvote. The phase two study will be undertaken in patients with advanced clear cell renal cell carcinoma (ccRCC), which is the most common and aggressive form of kidney cancer. 382 fib retrace from that big run up and broke the longer term MA, RSI went into oversold; price rebounded to ~$12. "Telix (ASX: TLX) listed on the 15 th of November at an IPO price 280% above its pre-IPO price. Many of us here are investors and to some, having BEAR talk in your. Hi all I thought i would start a thread to talk about short-term trading or analysis. This thing should be $10+. Search pre-owned Acura TLX listings to find the best Victoria, BC deals. 59pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on TELSTRA GROUP LIMITED. The web page shows its share price, news, discussions and timeline. Discuss your favourite stocks with more than 250,000 members. TLX could double to $6BN AUD and be cheap, once a bit more of its pipeline is confirmed positive trial results. The takeaways for this stock is as follow; I put the stock at an intrinsic value of 3. $1. Two tlx doses over 14 days vs 6 doses Novartis . . Sales were primarily driven by the United States, where the prostate cancer diagnostics market, which is valued at around $3 billion, is. $8 coming, page-8. invited to the high school prom. ASX - By Stock. TLX Price at posting: $11. LNTH is at 6bn, in USD. ~mid-April: TLX rerates, 2 gaps remain in chart @ ~ $8. cooperated with Telix Pharmaceuticals Limited (ASX: TLX) and ITM Isotope Technologies Munich SE to establish a world-class tumor intervention R&D platform and a radionuclide-drug conjugate R&D platform. 0¢. 382 fib retrace from that big run up and broke the longer term MA, RSI went into oversold; price rebounded to ~$12. 3x) compared to the AU Biotechs industry average (-3; The present value of this stock at 4. TLX. Latest Posts. Share something technical analysis wont tell you is when an external event will affect a share price. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. ASX - By Stock. Latest Posts. Created with Sketch. Market . Search pre-owned 2018 Acura TLX V6 SH-AWD with Technology and A-Spec. Share something technical analysis wont tell you is when an external event will affect a share price. All the latest Telix Pharmaceuticals (ASX:TLX) share price movements, news, expert commentary and investing advice from. July 19 (Reuters) - Telix Pharmaceuticals Ltd (TLX) : QTRLY ADJUSTED EBITDAR UP 24% QOQ TO A$45. Share something technical analysis wont tell you is when an external event will affect a share price. Most days you can get $1000 or $2000 if you get it half right. Lunch Time Top 5 #MostDiscussedStocks: $NVX $TLX $MAY $SYA $PLS #asx #ausbiz 20 Oct 2022 01:05:01Close Top 5 #MostDiscussedStocks: $TLX $SYA $FFX $LKE $LTR #asx #ausbiz 22 Jul 2022Lunch Time Top 5 #MostDiscussedStocks: $TLX $LKE $LTR $PNV $SYA #asx #ausbiz 22 Jul 2022Market Open Top 5 #MostDiscussedStocks: $WHC $SYA $CXO $TLX $CRR #asx #ausbiz 28 Sep 2022 00:11:01Top Shareholders Data provided by Morningstar. Market . HotCopper was voted Australia’s best Stock Forum by independent website The Bull for the last 3 years. Last updated 15. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?It's possible that a cap raise is coming. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. Share something technical analysis wont tell you is when an external event will affect a share price. 63/share valuation. It has. If expenses stay in line with the preceeding quarter then outgoings should be ~75m. $9bn in AUD, 3 times TLX valuation and rising daily. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?Share U. 15 TELIX PHARMACEUTICALS LIMITED - Discussion. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. Hi all I thought i would start a thread to talk about short-term trading or analysis. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. Stay ahead of the market. . . 1. still cheap. Nov 21 (Reuters) - Telix Pharmaceuticals Ltd (TLX) : FIRST PATIENT DOSED IN PHASE II 'IPAX-LINZ' STUDY OF TLX101 FOR GLIOBLASTOMA THERAPY. ) based clinical stage company developing therapeutic radiopharmaceuticals for primary and metastatic bone. its fundamentals. Created with Sketch. and ive been told by TLX itself that they dont have a salesforce for it etc. Second, I wanna point that TLX has been hiring HR staff as well as People & Culture DIrector/Officer(s) during this period and even more most recently, so perhaps this is becoming a priority for the company now since it's. Volume. Latest Posts. Forex. 30pm EDT. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?April 17 (Reuters) - Telix Pharmaceuticals Ltd (TLX) : TOTAL REVENUE FOR QUARTER REACHES A$100. ASX - By Stock. . 62 going off available shares and data. Interior Color: Espresso. Pluvicto is their therapy product and the fastest growing product in the Novartis suite of products prior to using Pluvicto, patients must be screened with either Locametz or Share something technical analysis wont tell you is when an external event will affect a share price. 6% POSITIVES. How low will it go?Here are a few clues. I am sure TLX would love to report triple figure sales for the quarter. Forums. Share something technical analysis wont tell you is when an external event will affect a share price. Share something technical analysis wont tell you is when an external event will affect a share price. Telix reports fourth consecutive quarter of positive operating cash flow PR Newswire MELBOURNE, Australia, Oct. MELBOURNE, Australia and INDIANAPOLIS, May 25, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it will host an education session for investors on Wednesday, June 21, 2023, at The Yale Club in New York City, from 8. Share. ASX - By Stock. Hi all, I jumped in TLX today - currently trying to break out. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. Join the HotCopper ASX share market forum today for free. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?June 22 (Reuters) - Telix Pharmaceuticals (TLX. Advertise on HotCopper. Share something technical analysis wont tell you is when an external event will affect a share price. Not sure it’d be any different… I enjoy watching TLX becoming an up-and-coming pillar of ASX. I am a very long term holder and accumulator of TLX. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. Under the agreement, the companies will work together to develop and produce Actinium-225 for use in drug development and commercial sales. That's my "aspirational" 4C for the company. Interesting, thanks for sharing. Charts. Last updated 11. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?I'm sure TLX crunched some numbers internally and know more than we do, but up till this point they haven't communicated officially on this. 262516. ASX - Day Tradingwasnt it TLX 591 that dished out overall survival benefits of 36 months as opposed to Pluvicto at 8 months ? (id check my facts here, just going off memory) timeline wise. ASX - Short Term Trading. ASX - Day Trading. Surely the Varian bid for SRX shines a light on TLX?, page-2. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. Telix Pharmaceuticals (TLX) 2022 sees Telix become a commercial entity withfirst approved product in ILLUCCIX. 0. Put your Investment Case to Hotcopper's 700K monthly unique visitors. Commodities. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. AX) ASX - ASX Delayed price. 37 . 36. Target our investor community with our suite of Hotcopper Advertising. Pluvicto is their therapy product and the fastest growing product in the Novartis suite of products prior to using Pluvicto, patients must be screened with either Locametz or so long as TLX stops exceeding analysts expectations, slows growth, and becomes careless with R&D expenses, then yes the SP may rise like you wish. Pluvicto is their therapy product and the fastest growing product in the Novartis suite of products prior to using Pluvicto, patients must be screened with either Locametz or Still, some exceptions include software business WiseTech Global which floated on the ASX at $3. Share i think id quite enjoy a failed takeover approach (sorry again, but SRX had one in early days) would put a spotlight on TLX with 80% of the company held by 15% shareholders, would seem unlikely. Market . April 27 (Reuters) - Telix Pharmaceuticals Ltd (TLX) : ANNOUNCES EXPANSION OF ITS ARTIFICIAL INTELLIGENCE CAPABILITY EXPANSION OF AI CAPABILITY WITH. to put the price swing into perspective, TLX rallied from $8 to $9 last quarter result, a 12% increase. , page-6. ) lutetium-177 (177Lu), a therapeutic isotope used in Telix’s portfolio of molecularly targeted radiation (MTR). The TLX product is in a kit form, which circumvents the lengthy synthesis process into a 10 minute prep. . while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. Hi all, I jumped in TLX today - currently trying to break out. Add ~1500 men a week for the first ~6 weeks of the quarter, thats an additional $45 million (approx $115 million altogether, someone may correct me on those figures). I wouldn’t touch RAD. Last edited by spnc: 31/08/23. ASX - Day Trading2. Created with Sketch. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. 4% so far today? Issuing shares and options seems to come at a big cost to existing shareholders. Our sense is that the valuation can remain north of 20x EV/revenue on the basis of ILLUCCIX sales execution and that implies share price growth towards $10. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?$8 coming, page-21. 65Share something technical analysis wont tell you is when an external event will affect a share price. $8 coming, page-21. When the full year report for 2022 was released earlier this year it showed ~$39 million in trade and receivables as of 31st December 2022, with the following 4C report for Jan-Mar quarter 2023 showing ~$83 million receipts of which the $39 million receivables eventually accounted for nearly half. Share something technical analysis wont tell you is when an external event will affect a share price. 55403. Created with Sketch. 11/08/22 23:42 Post #: 63068464 Share Aug 11, 2022 – 5. ASX - Short Term Trading. The study will. While Telix and Lantheus currently have the market to themselves, there’s a staggering level of competition waiting to join the race: industry-wide, there are around 100 nuclear therapies currently in development with twice as many nuclear-based imaging products. $953. Share something technical analysis wont tell you is when an external event will affect a share price. 07 Sentiment: None Disclosure: Held Likesif TLX can continue to grow Illuccix by close to 19% per quarter then TLX is not a $500 million Revenue generating company $120m $140m $ 170m $200 its significantly over $600 million in revenues plus ive noticed Ex USA has jumped about 80% from 2. ASX - Day Trading. 30am – 12. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. Share something technical analysis wont tell you is when an external event will affect a share price. ASX - Short Term Trading. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?22,675,000 x 2 = 45, 350, 000 × 8. Share something technical analysis wont tell you is when an external event will affect a share price. Join the HotCopper ASX share market forum today for free. -4. On Hotcopper forum, the discussion was rife, As members like @ajostu, and @banff gave. 90 and $7. currently the SP seems to drop every time cb or Tlx provide positive results. Market Cap $2. We are thrilled to announce that the prostate cancer imaging agent Illuccix®, also known as PSMA-11, which we distribute, is now available in Canada. The web page shows its share price, news, discussions and timeline on HotCopper Forum. Market . thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?The FDA is expected to announce a decision before September 23. 48. Created with Sketch. Many of us here are investors and to some, having BEAR talk in your. 50247. ASX - By Stock. Share Is this why the share price has dropped 4. TLX taking a pummelling over the past 2-3 weeks. gov. ASX - Day Trading. Share something technical analysis wont tell you is when an external event will affect a share price. You can see the latest updates on its business, results, partnerships and collaborations. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. 0. Charts. ~mid-April: TLX rerates, 2 gaps remain in chart @ ~ $8. Share something technical analysis wont tell you is when an external event will affect a share price. Claim your IR profile A new research note from Bell Potter reveals the broker is bullish on the demand for prostate cancer imaging products into 2031. kind of puts an increasing value on TLX with more than two experimental treatment drugs , plus imaging on several fronts, Eu and Asia. Join the HotCopper ASX share market forum today for free. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. 52% $9. 4L with Technology Package. 90 and $7. 63% annual earnings growth after Phase trials are complete. ASX - Day Trading. Bell Potter has upgraded its target price for Telix to $9. The drugmaker fixed the quality issues that led to voluntary production halts at its radioligand therapy sites in Ivrea, Italy, and Millburn, New Jersey, Novartis said Thursday. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss. 91 Sentiment: Buy Disclosure: Held. 9¢. 30am – 12. ASX - Short Term Trading. 4L Inline-4 Gas (206hp) Transmission: The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for Pluvicto ® (lutetium [177 Lu] vipivotide tetraxetan), for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane. Charts. Anthony Noble. Exterior Color: Black Copper Pearl. As for the company's pipeline, he's excited about the prospect of TLX launching two new products in 2024, subject to regulatory approval. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. Join the HotCopper ASX share. Novartis treat the toilet bowl . Become a member of Australia's largest investment discussion forum. Assets are very early stage and undifferentiated. 01, which suggests around 26% upside to the $7. The Company's deep pipeline for prostate, kidney, brain (glioblastoma), and hematologic cancers, and rare diseases is underpinned by a reliable and secure global supply chain, manufacturing. Created with Sketch. You can see the pullback is low volume in comparison to the breakout buying volume. Bannan, a portfolio manager in small caps fund run by the $215bn IFM Investors’ group, said the company which was listed on the ASX in 2017 was. Volume. Hi all, I jumped in TLX today - currently trying to break out. company has not alluded to what these "manufacturing associated" observations are, so its difficult to say what type of hit TLX will suffer today, but TLX will be deep in the red today. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. 9. Share something technical analysis wont tell you is when an external event will affect a share price. 35%. Share something technical analysis wont tell you is when an external event will affect a share price. 27, 2023 /PRNewswire/— Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) haswelcomed Her Royal Highness, PrincessAstrid, Princess of Belgium toTelix Manufacturing Solutions (TMS), the Company’s recently inauguratedproduction facility, in Brussels South (Seneffe) in the. TLX produces a 'cold' kit of their probe, and in the hospital their probe is mixed with Galium-68 produced by the generator (the Galium binds to the probe), which is much simpler than doing the fluorine chemistry and purification. View today’s TLX share price, options, bonds, hybrids and warrants. 59%) As of 01:36PM AEDT. 10. Share something technical analysis wont tell you is when an external event will affect a share price. we are in the weaker part of the year so Inexpect higher prices for TLX but maybe not a for a month or 2 which is why we probably go down (to remove the selling pressure) before we go up. 0¢. TLX Price at posting: $7. . Chairman and CEO Albert Bourla said in a statement that oncology is “the largest growth driver in global medicine, and this acquisition will enhance Pfizer’s position in this important space. TLX Price at posting: $9. Last updated 15. news must be imminentMetal Bank continues to announce High-Grade Copper results at Malaqa, JordanTLX Shareholders Hello. we are in the weaker part of the year so Inexpect higher prices for TLX but maybe not a for a month or 2 which is why we probably go down (to remove the selling pressure) before we go up. commercial update In Q3 2022, the second quarter of commercial sales, Telix generated $53. If the FDA does not consider the response to be satisfactory, then they will issue a complete response letter and the SP will go down around another 30-40%. Report Created with Sketch. DJPIN. Timeline. a. Many of us here are investors and to some, having BEAR talk in your. ASX - General. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. The UK’s regulator approved Novartis’ radioligand therapy Pluvicto ® and radioactive diagnostic agent Locametz ® for use in advanced prostate cancer. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a new global clinical supply agreement with Wisconsin-based SHINE Technologies, LLC (SHINE) for highly pure no-carrier-added (n. Dr Christian Behrenbruch, Managing Director and Group CEO of Telix said, “The transaction with Lightpoint brings a compelling commercial-stage asset to Telix that has the potential to transform the use of radiopharmaceuticals in the interventional setting, with commensurate impact on Telix’s market share for Illuccix. Created with Sketch. Now it's true that there will be less competition for TLX on the EMEA front, which can only be a good thing for TAM. TLX will soon be a revenue-generating company (with several products in the pipeline), and IMO, if the figures they have thrown out there are even close to being accurate, the current SP is an absolute bargain. Market open. 50 a share approx Lots of differences but Telix is positioned for much larger growth and market opportunities than WTC in my opinion. Share something technical analysis wont tell you is when an external event will affect a share price. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?and that $4B is cheap for TLX at this stage. nappy off, dummy in the bin at $10 its showing some real potential and fun to watch the growth spurts maybe at $18 (god willing) , it will be on early data readouts and like a kid who just topped his school HSC. S. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. Unfortunate timing for. Telix Pharmaceuticals (ASX:TLX)IFM Investors’ executive director, Rikki Bannan, has tipped ASX listed cancer diagnostics company, Telix Pharmaceuticals, for her Sohn stock market tip. ASX - Day Trading. I'm going to load up. 83. 35-40% of that market, which is twice as much the AUD $400. . TLX quote a study they are involved in, led by Memorial Sloan kettering in NYC - results will presumably support those of the Australian study, which will boost interest. Price drop as the experts interpret the trial results as BAD. Created with Sketch. 84280. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?I was asked to look at TLX on another forum by someone looking for a breakout a few weeks back. PR Newswire MELBOURNE, Australia, May 7, 2023 MELBOURNE, Australia, May 7, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX:TLX, Telix, the Company) today announces that it has entered into an agreement with BayerAG (Bayer) to supply Illuccix(R) (TLX591-CDx, kit for the preparation of gallium Ga 68gozetotide injection)([1]) for the Phase III ARASTEP study (ClinicalTrials. We analyze hundreds of thousands of used cars daily. 16789665. Forums. $8 coming, page-2. Telix Pharmaceuticals (ASX:TLX)IFM Investors’ executive director, Rikki Bannan, has tipped ASX listed cancer diagnostics company, Telix Pharmaceuticals, for her Sohn stock market tip. 1. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a conditional Term Sheet to acquire QSAM Biosciences, Inc. TLX is the ASX code for Telix Pharmaceuticals Limited, a radiopharmaceutical company based in Australia. Share something technical analysis wont tell you is when an external event will affect a share price. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. 51. Target our investor community with our. ASX - Short Term Trading. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. Share something technical analysis wont tell you is when an external event will affect a share price. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. David Williams, Managing Director of Kidder Williams, said “China Grand Pharma is opening new markets to some of Australia’s best technology and supporting. 947193. Not so much great volume, but this second attempt MIGHT stick. 0¢. Join the HotCopper ASX share market forum today for free. ASX - General. . The TLX crew are pretty well behaved compared to the lithium crew. Share something technical analysis wont tell you is when an external event will affect a share price. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and. 2% per year. -18. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. Application for quotation of securities - TLX. 90 ~June 10th: the low on the pullback was bang on the . 11. 21. Last updated 15. Forums. Join the HotCopper ASX share market forum today for free. While Albanese (who lands back in Australia on budget eve) basks in the. July 19 (Reuters) - Telix Pharmaceuticals Ltd (TLX) : QTRLY TOTAL REVENUE UP 21% QUARTER-ON-QUARTER TO A$120. Then biotech industry should just shut down altogether . Latest Posts. Charts. Share something technical analysis wont tell you is when an external event will affect a share price. while many comments keep referring to how successful tlx has been and how sales are growing, nobody has commented on the recent share price declines of resmed, csl and other health care stocks due to the impact of wegovy, ozempic and other weight loss drugs. thats about half of TLX whole value right now or say, $5 per share whichever currency you want to use hypothetically, if TLX put that into another empty shell or vehicle as stand-alone - XYZ company, what would that company be valued at on the ASX ? less than a year away from commercial sales and FDA approval imminent/ around corner ?The Board announces that it has initiated a partial divestment of the Group’s shareholding in Telix Pharmaceuticals Limited (“Telix”, a company listed in the Australian Securities Exchange, stock code: TLX) to sell, off the market, approximately half of its holding (10,000,000 shares) in Telix at a value of approximately AU$73 million. $1.